Outpatient Oncology Infusion Market Size

Outpatient Oncology Infusion Market size was valued at USD 79.1 billion in 2023 and is expected to cross USD 266.7 billion by the end of 2036, expanding at more than 11.5% CAGR during the forecast period i.e., between 2024-2036. In 2024, the industry size of outpatient oncology infusion is assessed at USD 93.5 billion.

The outpatient oncology infusion market is driven by the increasing prevalence of cancer and the corresponding rise in demand for oncology treatments. The global incidence of cancer continues to rise due to aging populations, lifestyle, and environmental factors. As more individuals are diagnosed with cancer, there is a greater need for oncology treatments, including infusion therapies administered in outpatient settings. A 2024 report published by the World Health Organization (WHO) stated that in 2022, there were about 20 million new cancer cases and 9.7 million deaths, and over 35 million new cancer cases are expected in 2050. There is a growing preference among patients and healthcare providers for outpatient care due to its cost-effectiveness, convenience, and ability to provide specialized treatments without hospitalization. This shift has led to the expansion of outpatient infusion settings specializing in oncology treatments.